Alogliptin Benzoate and Pioglitazone hydrochloride
Drug Details
- Generic Name
- Alogliptin Benzoate and Pioglitazone hydrochloride
- Brand Names
- Alogliptin and Pioglitazone
- Application Number
- NDA022426
- Sponsor
- Padagis Israel Pharmaceuticals Ltd
- NDC Codes
- 4
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Alogliptin and pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus . Alogliptin and pioglitazone tablets are a combination of alogliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone, a thiazolidinedione agonist of peroxisome proliferator receptor gamma, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use: Alogliptin and pioglitazone tablets are not recommended for use in patients with type 1 diabetes mellitus. ( 1 ) Limitations of Use Alogliptin and pioglitazone tablets are not recommended for use in patients with type 1 diabetes mellitus.